Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis
暂无分享,去创建一个
[1] Qing Yang,et al. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins , 2016, British Journal of Cancer.
[2] Shivakumar Keerthikumar,et al. ExoCarta: A Web-Based Compendium of Exosomal Cargo. , 2016, Journal of molecular biology.
[3] Y. Loh,et al. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma , 2016, Tumor Biology.
[4] José G. Pérez-Silva,et al. The Degradome database: expanding roles of mammalian proteases in life and disease , 2015, Nucleic Acids Res..
[5] A. Jemal,et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women , 2016, CA: a cancer journal for clinicians.
[6] J. Joyce,et al. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response , 2015, Nature Reviews Cancer.
[7] N. Gutowski,et al. The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer , 2015, Biomolecules.
[8] Alexander G. Gray,et al. Highly-accurate metabolomic detection of early-stage ovarian cancer , 2015, Scientific Reports.
[9] John D. Venable,et al. ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity. , 2015, Journal of proteomics.
[10] B. Domon,et al. Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype‐specific PRM assays , 2015, Proteomics.
[11] K. Kojima,et al. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer , 2015, Journal of Clinical Pathology.
[12] R. Linding,et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase , 2015, Nature.
[13] Lishan Sun,et al. Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis , 2015, Arthritis Research & Therapy.
[14] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[15] María Martín,et al. UniProt: A hub for protein information , 2015 .
[16] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[17] The Uniprot Consortium,et al. UniProt: a hub for protein information , 2014, Nucleic Acids Res..
[18] A. Naderi. Prolactin-induced protein in breast cancer. , 2015, Advances in experimental medicine and biology.
[19] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[20] George A Calin,et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.
[21] J. Joyce,et al. Pericellular proteolysis in cancer , 2014, Genes & development.
[22] A. Varki,et al. Lectin Galactoside-binding Soluble 3 Binding Protein (LGALS3BP) Is a Tumor-associated Immunomodulatory Ligand for CD33-related Siglecs* , 2014, The Journal of Biological Chemistry.
[23] K. Kinzler,et al. Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies , 2014 .
[24] M. Zhang,et al. Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma , 2014, Breast Cancer Research.
[25] H. Lincet,et al. How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? , 2014, Oncogene.
[26] J. Yates,et al. Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and Treatment , 2014, PloS one.
[27] Bert Vogelstein,et al. DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES , 2014 .
[28] Peilin Huang,et al. Alpha-2-Glycoprotein 1(AZGP1) Regulates Biological Behaviors of LoVo Cells by Down-Regulating mTOR Signaling Pathway and Endogenous Fatty Acid Synthesis , 2014, PloS one.
[29] Denis Wirtz,et al. Hypoxia and the extracellular matrix: drivers of tumour metastasis , 2014, Nature Reviews Cancer.
[30] K. O'Byrne,et al. Functions and Therapeutic Roles of Exosomes in Cancer , 2014, Front. Oncol..
[31] D. Chan,et al. Biomarkers in prostate cancer: what's new? , 2014, Current opinion in oncology.
[32] R. Baxter,et al. IGF binding proteins in cancer: mechanistic and clinical insights , 2014, Nature Reviews Cancer.
[33] F. Tas,et al. Clinical significance of serum tenascin-C levels in breast cancer , 2014, Tumor Biology.
[34] Toshima Z. Parris,et al. Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma , 2014, International journal of cancer.
[35] Mack T. Ruffin,et al. Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis , 2014, Journal of proteome research.
[36] C. Perou,et al. Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures , 2014, Breast Cancer Research and Treatment.
[37] Chun-yu Huang,et al. Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer , 2013, PloS one.
[38] S. Ciatto,et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. , 2013, The Lancet. Oncology.
[39] S. Nordling,et al. PSA forms complexes with α1‐antichymotrypsin in prostate , 2013, The Prostate.
[40] A. Bleyer,et al. Effect of three decades of screening mammography on breast-cancer incidence. , 2012, The New England journal of medicine.
[41] A. Masood,et al. Role of proteases in cancer: A review , 2012 .
[42] R. Saxton,et al. Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid. , 2012, Journal of proteome research.
[43] R. Akhurst,et al. Complexities of TGF-β Targeted Cancer Therapy , 2012, International journal of biological sciences.
[44] S. Hanash,et al. Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. , 2012, Cancer research.
[45] W. Wetsel,et al. New roles of carboxypeptidase E in endocrine and neural function and cancer. , 2012, Endocrine reviews.
[46] N. Shinohara,et al. Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells , 2012, British Journal of Cancer.
[47] S. Cross,et al. iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer , 2012, PloS one.
[48] P. Gimotty,et al. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer. , 2012, Journal of proteome research.
[49] Kuan-Ting Lin,et al. Serine Protease PRSS23 Is Upregulated by Estrogen Receptor α and Associated with Proliferation of Breast Cancer Cells , 2012, PloS one.
[50] R. Sachidanandam,et al. IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer , 2012, Journal of Ovarian Research.
[51] N. Tinari,et al. LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis , 2012, Journal of Molecular Medicine.
[52] Yongliang Zhao,et al. The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression , 2012, BMC Cancer.
[53] Zhiming Zhang,et al. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer , 2012, BMC Cancer.
[54] R. Dahiya,et al. IGFBP‐4 activates the Wnt/beta‐catenin signaling pathway and induces M‐CAM expression in human renal cell carcinoma , 2011, International journal of cancer.
[55] J. Kench,et al. Low AZGP1 expression predicts for recurrence in margin‐positive, localized prostate cancer , 2011, The Prostate.
[56] Yan Li,et al. Overexpression of Cathepsin Z Contributes to Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma , 2011, PloS one.
[57] P. Fisher,et al. Insulin-like Growth Factor–Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma , 2011, Clinical Cancer Research.
[58] Jun Zhou,et al. TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells. , 2011, Cancer letters.
[59] Yi Lu,et al. Optimizing a 3D Culture System to Study the Interaction between Epithelial Breast Cancer and Its Surrounding Fibroblasts , 2011, Journal of Cancer.
[60] L. Newman,et al. Higher population‐based incidence rates of triple‐negative breast cancer among young African‐American women , 2011, Cancer.
[61] Shuo-Hui Hung,et al. Discrimination of breast cancer by measuring prostate-specific antigen levels in women's serum. , 2011, Analytical chemistry.
[62] B. Reina-San-Martin,et al. Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice , 2011, Oncogene.
[63] A. Sawa,et al. The diverse functions of GAPDH: views from different subcellular compartments. , 2011, Cellular signalling.
[64] A. Jemal,et al. Global Cancer Statistics , 2011 .
[65] Y. Loh,et al. Carboxypeptidase E: Elevated Expression Correlated with Tumor Growth and Metastasis in Pheochromocytomas and Other Cancers , 2010, Cellular and Molecular Neurobiology.
[66] L. Newman,et al. African ancestry and higher prevalence of triple‐negative breast cancer , 2010, Cancer.
[67] Ronald J. Moore,et al. Blood Peptidome-Degradome Profile of Breast Cancer , 2010, PloS one.
[68] C. Cohen,et al. Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma , 2010, Diagnostic pathology.
[69] T. Veenstra,et al. The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo , 2010, BMC medicine.
[70] B. Dunn,et al. Health disparities in breast cancer: biology meets socioeconomic status , 2010, Breast Cancer Research and Treatment.
[71] J. Bunkenborg,et al. Up‐regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast , 2010, Molecular oncology.
[72] Jeffrey W. Smith,et al. Mass Spectrometry-Based Label-Free Quantitative Proteomics , 2009, Journal of biomedicine & biotechnology.
[73] Z. Szallasi,et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.
[74] A. Nardulli,et al. Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues , 2010, BMC Cancer.
[75] N Harbeck,et al. Triple-negative breast cancer--current status and future directions. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[76] Wei Zhang,et al. Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas. , 2009, Neuro-oncology.
[77] Zhong-ying Shen,et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma , 2009, BMC Cancer.
[78] D. Radisky,et al. Single proteins might have dual but related functions in intracellular and extracellular microenvironments , 2009, Nature Reviews Molecular Cell Biology.
[79] Wei Zhang,et al. Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer , 2008, Breast Cancer Research.
[80] Shibo Jiang,et al. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. , 2008, Genes & development.
[81] G. Leto,et al. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[82] R. Coates,et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA , 2008, Breast Cancer Research and Treatment.
[83] D. El-Ashry,et al. Reversal of the Estrogen Receptor–Negative Phenotype in Breast Cancer and Restoration of Antiestrogen Response , 2007, Clinical Cancer Research.
[84] Xuchen Cao,et al. Expression level of insulin‐like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer , 2007, Cancer science.
[85] Genee Y. Lee,et al. The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.
[86] Genee Y. Lee,et al. Three-dimensional culture models of normal and malignant breast epithelial cells , 2007, Nature Methods.
[87] W. Ruan,et al. IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis , 2007, Cancer biology & therapy.
[88] J. Kench,et al. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy. , 2006, Journal of the National Cancer Institute.
[89] S. Hanash,et al. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. , 2006, Gastroenterology.
[90] Edward R B McCabe,et al. Single-gene disorders: what role could moonlighting enzymes play? , 2005, American journal of human genetics.
[91] C. Busch,et al. Significant expression of IGFBP2 in breast cancer compared with benign lesions , 2005, Journal of Clinical Pathology.
[92] Chi V Dang,et al. Multifaceted roles of glycolytic enzymes. , 2005, Trends in biochemical sciences.
[93] R. Sandberg,et al. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[94] I. Shmulevich,et al. Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion , 2005, Molecular Cancer.
[95] John D. Venable,et al. MS1, MS2, and SQT-three unified, compact, and easily parsed file formats for the storage of shotgun proteomic spectra and identifications. , 2004, Rapid communications in mass spectrometry : RCM.
[96] S. Cheung,et al. Clinical Significance of Thrombospondin 1 Expression in Hepatocellular Carcinoma , 2004, Clinical Cancer Research.
[97] J. Yates,et al. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. , 2004, Analytical chemistry.
[98] E. Bruyneel,et al. Trefoil factor family (TFF) peptides and cancer progression , 2004, Peptides.
[99] K. Sandelin,et al. Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment , 2004, Molecular & Cellular Proteomics.
[100] Jayanta Debnath,et al. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.
[101] Joshua E. Elias,et al. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. , 2003, Journal of proteome research.
[102] H. Friess,et al. Induction and expression of βig-h3 in pancreatic cancer cells , 2002 .
[103] Sara J. Prest,et al. The estrogen‐regulated protein, TFF1, stimulates migration of human breast cancer cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[104] H. Friess,et al. Induction and expression of betaig-h3 in pancreatic cancer cells. , 2002, Biochimica et biophysica acta.
[105] Charles M. Perou,et al. A Comparison of Gene Expression Signatures from Breast Tumors and Breast Tissue Derived Cell Lines , 2002, Disease markers.
[106] J. Yates,et al. An automated multidimensional protein identification technology for shotgun proteomics. , 2001, Analytical chemistry.
[107] L. Thim,et al. Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. , 2001, American journal of respiratory cell and molecular biology.
[108] J. Yates,et al. Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.
[109] D. Taupin,et al. Distinct Pathways of Cell Migration and Antiapoptotic Response to Epithelial Injury: Structure-Function Analysis of Human Intestinal Trefoil Factor , 2000, Molecular and Cellular Biology.
[110] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[111] E. Diamandis,et al. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[112] Marcel Garcia,et al. Biological and Clinical Significance of Cathepsin D in Breast Cancer Metastasis , 1996, Stem cells.
[113] C. Osborne,et al. Growth factors as mediators of estrogen/antiestrogen action in human breast cancer cells. , 1991, Cancer treatment and research.
[114] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[115] L. Murphy,et al. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. , 1987, Cancer research.
[116] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.